Fingerprint
Dive into the research topics of 'Indirect Treatment Comparisons of Mosunetuzumab With Third- and Later-Line Treatments for Relapsed/Refractory Follicular Lymphoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Indirect Treatment Comparisons of Mosunetuzumab With Third- and Later-Line Treatments for Relapsed/Refractory Follicular Lymphoma
Francesc Bosch, John Kuruvilla, Theodoros P. Vassilakopoulos, Danilo Di Maio, Michael C. Wei, Marie Helene Blanchet Zumofen, Loretta J. Nastoupil
Research output: Contribution to journal › Article › peer-review
1
Scopus
citations